HYBIO(SZ:300199) Xuan Gu Bao·2025-05-12 12:13Group 1: Stock Suspension and Resumption - Sunshine Nuohuo plans to acquire 100% equity of Langyan Life Science, leading to stock resumption. Langyan Life focuses on high-end chemical drugs and APIs, having established a mature pharmaceutical production system over the years [1] - Yunnan Copper is planning to purchase 40% equity of Liangshan Mining, resulting in stock suspension [2] Group 2: Mergers and Acquisitions - China Pharmaceutical intends to acquire 100% equity of Jinsui Technology for 302 million yuan. Jinsui Technology specializes in e-commerce operations, covering personal health consumer products and has established partnerships with well-known brands like Philips and Omron [3] Group 3: Share Buybacks and Increases - Tianqiao Hoisting's controlling shareholder plans to increase holdings of the company's shares by 75 million to 150 million yuan [4] Group 4: Investment Cooperation and Business Status - Kute Intelligent is collaborating with Huawei to upgrade AI Agent 2.0, expected to be completed by 2025 [5] - Heng'erda has completed the signing of an acquisition agreement for the German grinding machine company SMS [6] - Hongchang Technology plans to invest 15 million yuan in Guangdong Liangzhi Joint Technology, focusing on the humanoid robot industry chain [6] - Hongjing Technology intends to establish a wholly-owned subsidiary, Shenzhen Digital Zongheng Technology Co., Ltd., with an investment of 10 million yuan, focusing on AI hardware sales and innovation services [6] - Hanyu Pharmaceutical has signed a joint development agreement for a GLP-1R/GIPR/GCGR triple agonist peptide innovative drug with Carbon Cloud Smart Peptide [7] - Longsheng Technology's project with Silis for new energy vehicle motor semi-assemblies is expected to start supplying in the second half of 2025 [8] - Yihe Jiaye has signed a strategic cooperation framework agreement with Hanyu Pharmaceutical and Hanyu Health to develop a sleep health ecosystem [8] - Nanjing Steel's wholly-owned subsidiary successfully bid for the exploration rights of Fanqiao Iron Mine for 920 million yuan [9] - Wanda Film plans to invest in Lezi Tiancheng and engage in strategic cooperation [10] - CRRC has signed major contracts totaling 54.74 billion yuan, accounting for 22.2% of the company's projected revenue for 2024 under Chinese accounting standards [11] - Sileck has signed a strategic cooperation agreement with Lihua Power for the 46 series large cylindrical batteries [12]